Involvement of micro-calpain (CAPN 1) in muscle cell differentiation

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 4, 2004, Pages 728-743

  Moyen, Catherine ^a   Goudenege, Sébastien ^a   Poussard, Sylvie ^a   Sassi, Abdessattar Hadj ^a   Brustis, Jean Jacques ^a   Cottin, Patrick ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Bovine serum albumin; BSA; DMEM; Dulbecco's modified Eagle medium; F.U.; FCS; Fetal calf serum; Fluorescence unit; Horse serum; HS; MCS; MEF 2; MRFs; Multiple cloning site; Myocyte enhancer factor 2; Myogenic regulatory factors; Phenyl methylsulfonyl fluoride; PMSF

Indexed keywords

CALPAIN; CAVEOLIN; CYTOSKELETON PROTEIN; EZRIN; MICROCALPAIN; MYOGENIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME SUBSTRATE; GENE EXPRESSION SYSTEM; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE FIBRIL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REGULATORY MECHANISM;

ANIMALS; CALPAIN; CAVEOLIN 3; CAVEOLINS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CLONING, MOLECULAR; CYTOSKELETAL PROTEINS; DESMIN; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; DOXYCYCLINE; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; MICE; MUSCLE CELLS; MUSCLE FIBERS; MUSCLE PROTEINS; MYOD PROTEIN; MYOGENIC REGULATORY FACTOR 5; PHOSPHOPROTEINS; TRANS-ACTIVATORS; VIMENTIN;

BOVINAE; CICONIIFORMES; EQUUS CABALLUS;

EID: 1542358855     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00265-6     Document Type: Article

References (47)

1. 2+-activated neutral protease (muCANP) deduced from its cDNA sequence. FEBS Letters, 205, 313-317.
2. Arahata K., Sugita H. Dystrophin and the membrane hypothesis of muscular dystrophy. Trends in Pharmacological Sciences. 10:1989;437-439.
3. Azam M., Andrabi S.S., Sahr K.E., Kamath L., Kuliopulos A., Chishti A.H. Disruption of the mouse mu-calpain gene reveals an essential role in platelet function. Molecular and Cellular Biology. 21:2001;2213-2220.
4. Barnoy S., Glaser T., Kosower N.S. The calpain-calpastatin system and protein degradation in fusing myoblasts. Biochimica et Biophysica Acta. 1402:1998;52-60.
5. Bisbal C., Silhol M., Laubenthal H., Kaluza T., Carnac G., Milligan L., Le Roy F., Salhezada T. The 2′-5′ oligoadenylate/Rnase L/Rnase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Molecular and Cellular Biology. 20:2000;4959-4969.
6. Brustis J.J., Elamrani N., Balcerzak D., Safwate A., Soriano M., Poussard S., Cottin P., Ducastaing A. Rat myoblast fusion requires exteriorized m-calpain activity. European Journal of Cell Biology. 64:1994;320-327.
7. Carafoli E., Molinari M. Calpain: a protease in search of a function? Biochemical and Biophysical Research Communication1. 247:1998;193-203.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry. 162:1987;156-159.
9. 2+-dependent proteinases (calpains) and muscle cell differentiation. Biochimica et Biophysica Acta. 1223:1994;170-178.
10. Croall D.E., DeMartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiological Review. 71:1991;813-847.
11. Dahlmann B., Kuehn L., Reinauer H., Kay J., Stauber W.T. Muscle protein wasting in diabetes mellitus: role of proteases. Contributions to Nephrology. 73:1989;127-138.
12. Dargelos E., Dedieu S., Moyen C., Poussard S., Veschambre P., Brustis J.J., Cottin P. Characterization of the calcium-dependent proteolytic system in a mouse muscle cell line. Molecular and Cellular Biochemistry. 231:2002;147-154.
13. Dourdin N., Balcerzak D., Brustis J.J., Poussard S., Cottin P., Ducastaing A. Potential m-calpain substrates during myoblast fusion. Experimental Cell Research. 246:1999;433-442.
14. Dourdin N., Brustis J.J., Balcerzak D., Elamrani N., Poussard S., Cottin P., Ducastaing A. Myoblast fusion requires fibronectin degradation by exteriorized m-calpain. Experimental Cell Research. 235:1997;385-394.
15. Galbiati F., Razani B., Lisanti M.P. Caveolae and caveolin-3 in muscular dystrophy. Trends in Molecular Medicine. 7:2001;435-441.
16. Galbiati F., Volonte D., Engelman J.A., Scherer P.E., Lisanti M.P. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. Journal of Biological Chemistry. 274:1999;30315-30321.
17. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences of the United States of America. 89:1992;5547-5551.
18. Goll D.E., Thompson V.F., Taylor R.G., Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays. 14:1992;549-556.
19. Graham-Siegenthaler K., Gauthier S., Davies P.L., Elce J.S. Active recombinant rat calpain II. Bacterially produced large and small subunits associate both in vivo and in vitro. The Journal of Biological Chemistry. 269:1994;30457-30460.
20. Hasty P., Bradley A., Morris J.H., Edmondson D.G., Venuti J.M., Olson E.N., Klein W.H. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature. 364:1993;501-506.
21. Hinrichs W., Kisker C., Duvel M., Muller A., Tovar K., Hillen W., Saenger W. Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. Science. 264:1994;418-420.
22. Hussain T., Devi N.G., Kumari C.K., Anandaraj M.P. Deletion analysis and calpain status for carrier detection in a family with Duchenne muscular dystrophy. The Indian Journal of Medical Research. 108:1998;93-97.
23. Lindon C., Montarras D., Pinset C. Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts. Journal of Cell Biology. 140:1998;111-118.
24. 2+-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80 kDa form. The Journal of Biological Chemistry. 269:1994;27992-27995.
25. Moraczewski J., Piekarska E., Bonavaud S., Wosinska K., Chazaud B., Barlovatz-Meimon G. Differential intracellular distribution and activities of mu- and m-calpains during the differentiation of human myogenic cells in culture. Comptes Rendus de l' Academie des Sciences III. 319:1996;681-686.
26. Murachi T. Calcium-dependent proteinases and specific inhibitors: calpain and calpastatin. Biochemical Society Symposium. 49:1984;149-167.
27. Nabeshima Y., Hanaoka K., Hayasaka M., Esumi E., Li S., Nonaka I., Nabeshima Y. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 364:1993;532-535.
28. Pariat M., Salvat C., Bebien M., Brockly F., Altieri E., Carillo S., Jariel-Encontre I., Piechaczyk M. The sensibility of c-jun and c-fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers. Biochemical Journal. 345:2000;129-138.
29. Perrin B.J., Huttenlocher A. Calpain. The International Journal of Biochemistry and Cell Biology. 34:2002;722-725.
30. Poirier C., Poussard S., Faust D.M., Imaizumi-Scherrer T., Weiss M.C., Ducastaing A., Montarras D., Pinse C., Guenet J.L. Mapping, cloning, cDNA sequence, and expression of the gene encoding the mouse micromolar calpain large subunit. Mammalian Genome. 9:1998;388-389.
31. Poussard S., Cottin P., Brustis J.J., Talmat S., Elamrani N., Ducastaing A. Quantitative measurement of calpain I and II mRNAs in differentiating rat muscle cells using a competitive polymerase chain reaction method. Biochimie. 75:1993;885-890.
32. Poussard S., Duvert M., Balcerzak D., Ramassamy S., Brustis J.J., Cottin P., Ducastaing A. Evidence for implication of muscle-specific calpain (p94) in myofibrillar integrity. Cell Growth and Differentiation. 7:1996;1461-1469.
33. Sambrook, J., Fritsch, E. F., & Maniatis, T. (1989). Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory.
34. Shcherbina A., Bretscher A., Kenney D.M., Remold-O'Donnell E. Moesin, the major ERM protein of lymphocytes and platelets, differs from ezrin in its insensitivity to calpain. FEBS Letters. 443:1999;31-36.
35. Shumway S.D., Maki M., Miyamoto S. The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. Journal of Biological Chemistry. 274:1999;30874-30881.
36. Thompson V.F., Lawson K.R., Barlow J., Goll D.E. Digestion of mu- and m-calpain by trypsin and chymotrypsin. Biochimica et Biophysica Acta. 1648:2003;140-153.
37. Tidball J.G., Spencer M.J. Calpains and muscular dystrophies. The International Journal of Biochemistry and Cell Biology. 32:2000;1-5.
38. Twining S.S. Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes. Analytical Biochemistry. 143:1984;30-34.
39. Ueda Y., Wang M.C., Ou B.R., Huang J., Elce J., Tanaka K., Ichihara A., Forsberg N.E. Evidence for the participation of the proteasome and calpain in early phases of muscle cell differentiation. The International Journal of Biochemistry and Cell Biology. 30:1998;679-694.
40. Ueyama H., Kumamoto T., Fujimoto S., Murakami T., Tsuda T. Expression of three calpain isoform genes in human skeletal muscles. Journal of Neurological Sciences. 155:1998;163-169.
41. Walowitz J.L., Bradley M.E., Chen S., Lee T. Proteolytic regulation of the zinc finger transcription factor YY1, a repressor of muscle-restricted gene expression. The Journal of Biological Chemistry. 273:1998;6656-6661.
42. Watt F., Molloy P.L. Specific cleavage of transcription factors by the thiol protease, m-calpain. Nucleic Acids Research. 21:1993;5092-5100.
43. Wright W.E., Sassoon D.A., Lin V.K. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD1. Cell. 56:1989;607-617.
44. Xiao Y.Y., Wang M.C., Purintrapiban J., Forsberg N.E. Roles of mu-calpain in cultured L8 muscle cells: application of a skeletal muscle-specific gene expression system. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: CBP. 134:2003;439-450.
45. Yoshizawa T., Sorimachi H., Tomioka S., Ishiura S., Suzuki K. A catalytic subunit of calpain possesses full proteolytic activity. FEBS Letters. 358:1995a;101-103.
46. Yoshizawa T., Sorimachi H., Tomioka S., Ishiura S., Suzuki K. Calpain dissociates into subunits in the presence of calcium ions. Biochemical and Biophysical Research Communication. 208:1995b;376-383.
47. Yun K., Wold B. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Current Opinion in Cell Biology. 8:1996;877-889.